Molecular docking analysis reveals the functional inhibitory effect of Genistein and Quercetin on TMPRSS2: SARS-COV-2 cell entry facilitator spike protein

被引:21
|
作者
Manjunathan, Reji [1 ,2 ]
Periyaswami, Vijayalakshmi [3 ]
Mitra, Kartik [4 ]
Rosita, Arokiaraj Sherlin [5 ]
Pandya, Medha [6 ]
Selvaraj, Jayaraman [7 ]
Ravi, Lokesh [8 ]
Devarajan, Nalini [9 ]
Doble, Mukesh [4 ,10 ]
机构
[1] Univ Madras, Dr ALM Post Grad Inst Basic Med Sci, Dept Genet, Taramani Campus, Chennai, Tamil Nadu, India
[2] Chengalpattu Govt Med Coll & Hosp, Multidisciplinary Res Unit, Chengalpattu 603001, Tamil Nadu, India
[3] Bharathidasan Univ, Holy Cross Coll, Dept Biotechnol & Bioinformat, Trichy, Tamil Nadu, India
[4] Indian Inst Technol Madras, Dept Biotechnol, Bioengn & Drug Design Lab, Chennai, Tamil Nadu, India
[5] Bharathidasan Univ, Bishop Heber Coll Autonomous, Dept Bioinformat, Tiruchirapalli, Tamil Nadu, India
[6] Maharaja KrishnakumarSinhiji Bhavnagar Univ, KPES Sci Coll, Bhavnagar, Gujarat, India
[7] Saveetha Dent Coll & Hosp, Saveetha Inst Med & Tech Sci, Chennai, Tamil Nadu, India
[8] St Josephs Coll, Dept Bot, Bangalore, Karnataka, India
[9] Meenakshi Ammal Dent Coll, Cent Res Lab, Chennai, Tamil Nadu, India
[10] Saveetha Dent Coll & Hosp, Dept Cariol, Chennai 600077, Tamil Nadu, India
关键词
Transmembrane serine protease 2; SARS-Cov-2; coronavirus; Phyto compounds; Bioinformatics tools; Molecular docking; Molecular dynamics; ANGIOTENSIN-CONVERTING ENZYME; SIMULATIONS; BINDING; CANCER; ALPHA;
D O I
10.1186/s12859-022-04724-9
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Background The Transmembrane Serine Protease 2 (TMPRSS2) of human cell plays a significant role in proteolytic cleavage of SARS-Cov-2 coronavirus spike protein and subsequent priming to the receptor ACE2. Approaching TMPRSS2 as a therapeutic target for the inhibition of SARS-Cov-2 infection is highly promising. Hence, in the present study, we docked the binding efficacy of ten naturally available phyto compounds with known anti-viral potential with TMPRSS2. The aim is to identify the best phyto compound with a high functional affinity towards the active site of the TMPRSS2 with the aid of two different docking software. Molecular Dynamic Simulations were performed to analyse the conformational space of the binding pocket of the target protein with selected molecules. Results Docking analysis using PyRx version 0.8 along with AutoDockVina reveals that among the screened phyto compounds, Genistein shows the maximum binding affinity towards the hydrophobic substrate-binding site of TMPRSS2 with three hydrogen bonds interaction ( - 7.5 kcal/mol). On the other hand, molecular docking analysis using Schrodinger identified Quercetin as the most potent phyto compound with a maximum binding affinity towards the hydrophilic catalytic site of TMPRSS2 ( - 7.847 kcal/mol) with three hydrogen bonds interaction. The molecular dynamics simulation reveals that the Quercetin-TMPRSS complex is stable until 50 ns and forms stable interaction with the protein ( - 22.37 kcal/mol of MM-PBSA binding free energy). Genistein creates a weak interaction with the loop residues and hence has an unstable binding and exits from the binding pocket. Conclusion The compounds, Quercetin and Genistein, can inhibit the TMPRSS2 guided priming of the spike protein. The compounds could reduce the interaction of the host cell with the type I transmembrane glycoprotein to prevent the entry of the virus. The critical finding is that compared to Genistein, Quercetin exhibits higher binding affinity with the catalytic unit of TMPRSS2 and forms a stable complex with the target. Thus, enhancing our innate immunity by consuming foods rich in Quercetin and Genistein or developing a novel drug in the combination of Quercetin and Genistein could be the brilliant choices to prevent SARS-Cov-2 infection when we consider the present chaos associated with vaccines and anti-viral medicines.
引用
收藏
页数:15
相关论文
共 50 条
  • [21] In silico Molecular Docking Analysis Targeting SARS-CoV-2 Spike Protein and Selected Herbal Constituents
    Subbaiyan, Anbazhagan
    Ravichandran, Karthikeyan
    Singh, Shiv Varan
    Sankar, Muthu
    Thomas, Prasad
    Dhama, Kuldeep
    Malik, Yashpal S.
    Singh, Raj Kumar
    Chaudhuri, Pallab
    JOURNAL OF PURE AND APPLIED MICROBIOLOGY, 2020, 14 : 989 - 998
  • [22] Commentary: SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
    Djomkam, Alexandra Lindsey Zune
    Olwal, Charles Ochieng'
    Sala, Theodore Beyeme
    Paemka, Lily
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [23] Molecular docking, DFT analysis, and dynamics simulation of natural bioactive compounds targeting ACE2 and TMPRSS2 dual binding sites of spike protein of SARS CoV-2
    Yadav, Rohitash
    Hasan, Shazia
    Mahato, Sumit
    Celik, Ismail
    Mary, Y. S.
    Kumar, Ashish
    Dhamija, Puneet
    Sharma, Ambika
    Choudhary, Neha
    Chaudhary, Pankaj Kumar
    Kushwah, Ankita Singh
    Chaudhary, Jitendra Kumar
    JOURNAL OF MOLECULAR LIQUIDS, 2021, 342
  • [24] In Silico Molecular Characterization of Human TMPRSS2 Protease Polymorphic Variants and Associated SARS-CoV-2 Susceptibility
    Salleh, Mohd Zulkifli
    Deris, Zakuan Zainy
    LIFE-BASEL, 2022, 12 (02):
  • [25] Prevention of SARS-CoV-2 cell entry: insight from in silico interaction of drug-like alkaloids with spike glycoprotein, human ACE2, and TMPRSS2
    Gyebi, Gideon A.
    Adegunloye, Adegbenro P.
    Ibrahim, Ibrahim M.
    Ogunyemi, Oludare M.
    Afolabi, Saheed O.
    Ogunro, Olalekan B.
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (05) : 2121 - 2145
  • [26] Targeting the intestinal TMPRSS2 protease to prevent SARS-CoV-2 entry into enterocytes-prospects and challenges
    Mahmoud, Ismail Sami
    Jarrar, Yazun Bashir
    MOLECULAR BIOLOGY REPORTS, 2021, 48 (05) : 4667 - 4675
  • [27] Different residues in the SARS-CoV spike protein determine cleavage and activation by the host cell protease TMPRSS2
    Reinke, Lennart Michel
    Spiegel, Martin
    Plegge, Teresa
    Hartleib, Anika
    Nehlmeier, Inga
    Gierer, Stefanie
    Hoffmann, Markus
    Hofmann-Winkler, Heike
    Winkler, Michael
    Poehlmann, Stefan
    PLOS ONE, 2017, 12 (06):
  • [28] TMPRSS11D and TMPRSS13 Activate the SARS-CoV-2 Spike Protein
    Kishimoto, Mai
    Uemura, Kentaro
    Sanaki, Takao
    Sato, Akihiko
    Hall, William W.
    Kariwa, Hiroaki
    Orba, Yasuko
    Sawa, Hirofumi
    Sasaki, Michihito
    VIRUSES-BASEL, 2021, 13 (03):
  • [29] Molecular docking based comparative study of antiviral compounds on SARS-CoV-2 spike protein
    Nagavarapu, Sowmya
    Kumar, Jitendra
    Biswal, Pradyut K.
    NATURAL PRODUCT RESEARCH, 2024,
  • [30] Inhibitory effects of 190 compounds against SARS-CoV-2 Mpro protein: Molecular docking interactions
    Souza, Gabriella B.
    Sens, Larissa
    Hammerschmidt, Stefan J.
    de Sousa, Natalia F.
    de Carvalho, Maryelle A. G.
    Dos Santos, Carlos V. D.
    Tizziani, Tiago
    Moreira, Monalisa A.
    Pollo, Luiz A. E.
    Martin, Erlon F.
    Neto, Jose S. S.
    Biavatti, Maique W.
    de Assis, Francisco F.
    Ngadjui, Bonaventure T.
    Simo, Ingrid K.
    Ambassa, Pantaleon
    Scotti, Marcus T.
    Scotti, Luciana
    Braga, Antonio L.
    Schirmeister, Tanja
    Sandjo, Louis P.
    ARCHIV DER PHARMAZIE, 2023, 356 (08)